nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—PTGS2—muscle cancer	0.105	1	CbGaD
Cisplatin—hematologic cancer—muscle cancer	0.102	0.21	CtDrD
Cisplatin—urinary bladder cancer—muscle cancer	0.0781	0.161	CtDrD
Cisplatin—bone cancer—muscle cancer	0.0749	0.155	CtDrD
Cisplatin—testicular cancer—muscle cancer	0.0621	0.128	CtDrD
Cisplatin—germ cell cancer—muscle cancer	0.0594	0.123	CtDrD
Cisplatin—peripheral nervous system neoplasm—muscle cancer	0.0548	0.113	CtDrD
Cisplatin—lung cancer—muscle cancer	0.0534	0.11	CtDrD
Cisplatin—ABCC6—Dactinomycin—muscle cancer	0.0477	0.152	CbGbCtD
Cisplatin—GSTT1—Etoposide—muscle cancer	0.0469	0.15	CbGbCtD
Cisplatin—GSTP1—Etoposide—muscle cancer	0.0293	0.0935	CbGbCtD
Cisplatin—ABCC6—Etoposide—muscle cancer	0.0269	0.086	CbGbCtD
Cisplatin—NQO1—Doxorubicin—muscle cancer	0.022	0.0701	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—muscle cancer	0.0184	0.0586	CbGbCtD
Cisplatin—ABCC3—Vincristine—muscle cancer	0.0141	0.0451	CbGbCtD
Cisplatin—ABCC3—Etoposide—muscle cancer	0.0129	0.0413	CbGbCtD
Cisplatin—XDH—Doxorubicin—muscle cancer	0.0115	0.0366	CbGbCtD
Cisplatin—ABCG2—Dactinomycin—muscle cancer	0.00942	0.0301	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—muscle cancer	0.00883	0.0282	CbGbCtD
Cisplatin—ABCC3—Methotrexate—muscle cancer	0.00855	0.0273	CbGbCtD
Cisplatin—ABCC2—Vincristine—muscle cancer	0.00642	0.0205	CbGbCtD
Cisplatin—ABCC2—Etoposide—muscle cancer	0.00588	0.0188	CbGbCtD
Cisplatin—PTGS2—Etoposide—muscle cancer	0.00581	0.0185	CbGbCtD
Cisplatin—ABCG2—Vincristine—muscle cancer	0.0058	0.0185	CbGbCtD
Cisplatin—ABCG2—Etoposide—muscle cancer	0.00532	0.017	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—muscle cancer	0.00401	0.0128	CbGbCtD
Cisplatin—ABCC2—Methotrexate—muscle cancer	0.00389	0.0124	CbGbCtD
Cisplatin—ABCG2—Doxorubicin—muscle cancer	0.00363	0.0116	CbGbCtD
Cisplatin—ABCG2—Methotrexate—muscle cancer	0.00351	0.0112	CbGbCtD
Cisplatin—ABCB1—Dactinomycin—muscle cancer	0.0034	0.0108	CbGbCtD
Cisplatin—XDH—Effects of Nitric Oxide—MB—muscle cancer	0.00328	0.162	CbGpPWpGaD
Cisplatin—CYP2B6—Doxorubicin—muscle cancer	0.00255	0.00814	CbGbCtD
Cisplatin—ABCB1—Vincristine—muscle cancer	0.00209	0.00668	CbGbCtD
Cisplatin—ABCB1—Etoposide—muscle cancer	0.00192	0.00612	CbGbCtD
Cisplatin—BCHE—diaphragm—muscle cancer	0.00165	0.0602	CbGeAlD
Cisplatin—ABCB1—Doxorubicin—muscle cancer	0.00131	0.00417	CbGbCtD
Cisplatin—ABCB1—Methotrexate—muscle cancer	0.00127	0.00404	CbGbCtD
Cisplatin—ABCC6—Podofilox—Etoposide—muscle cancer	0.00113	1	CbGdCrCtD
Cisplatin—GSTP1—Diurnally Regulated Genes with Circadian Orthologs—MYF6—muscle cancer	0.000978	0.0483	CbGpPWpGaD
Cisplatin—SLC31A2—Copper homeostasis—FOXO1—muscle cancer	0.00084	0.0415	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—MYF6—muscle cancer	0.000735	0.0363	CbGpPWpGaD
Cisplatin—MT1A—renal system—muscle cancer	0.000641	0.0234	CbGeAlD
Cisplatin—MPO—C-MYB transcription factor network—MYF6—muscle cancer	0.000625	0.0309	CbGpPWpGaD
Cisplatin—CYP4A11—renal system—muscle cancer	0.000591	0.0215	CbGeAlD
Cisplatin—MT1A—Copper homeostasis—FOXO1—muscle cancer	0.000541	0.0268	CbGpPWpGaD
Cisplatin—MT2A—renal system—muscle cancer	0.000534	0.0195	CbGeAlD
Cisplatin—GSTT1—renal system—muscle cancer	0.000523	0.0191	CbGeAlD
Cisplatin—PTGS2—hindlimb—muscle cancer	0.000522	0.019	CbGeAlD
Cisplatin—ATP7B—cardiac atrium—muscle cancer	0.000515	0.0188	CbGeAlD
Cisplatin—SLC31A2—Copper homeostasis—MDM2—muscle cancer	0.000504	0.0249	CbGpPWpGaD
Cisplatin—ATP7A—renal system—muscle cancer	0.000463	0.0169	CbGeAlD
Cisplatin—PTGS2—appendage—muscle cancer	0.000448	0.0163	CbGeAlD
Cisplatin—CYP4A11—vagina—muscle cancer	0.000428	0.0156	CbGeAlD
Cisplatin—ABCC6—renal system—muscle cancer	0.000424	0.0155	CbGeAlD
Cisplatin—SOD1—smooth muscle tissue—muscle cancer	0.000421	0.0153	CbGeAlD
Cisplatin—ATP7B—vagina—muscle cancer	0.000416	0.0152	CbGeAlD
Cisplatin—MT1A—testis—muscle cancer	0.000414	0.0151	CbGeAlD
Cisplatin—ATP7B—Copper homeostasis—FOXO1—muscle cancer	0.00041	0.0203	CbGpPWpGaD
Cisplatin—SLC31A2—tendon—muscle cancer	0.00041	0.015	CbGeAlD
Cisplatin—SLC31A2—bone marrow—muscle cancer	0.000397	0.0145	CbGeAlD
Cisplatin—SLC31A1—renal system—muscle cancer	0.000394	0.0144	CbGeAlD
Cisplatin—XDH—renal system—muscle cancer	0.00039	0.0142	CbGeAlD
Cisplatin—GSTM1—renal system—muscle cancer	0.000385	0.014	CbGeAlD
Cisplatin—ATP7B—head—muscle cancer	0.000384	0.014	CbGeAlD
Cisplatin—SLC31A2—vagina—muscle cancer	0.00038	0.0139	CbGeAlD
Cisplatin—ATP7B—testis—muscle cancer	0.000371	0.0135	CbGeAlD
Cisplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—TP63—muscle cancer	0.000364	0.018	CbGpPWpGaD
Cisplatin—SOD1—cardiac atrium—muscle cancer	0.000363	0.0132	CbGeAlD
Cisplatin—ATP7A—tendon—muscle cancer	0.000361	0.0132	CbGeAlD
Cisplatin—MT2A—head—muscle cancer	0.000357	0.013	CbGeAlD
Cisplatin—SLC31A1—cardiac atrium—muscle cancer	0.000353	0.0129	CbGeAlD
Cisplatin—SLC31A2—head—muscle cancer	0.000351	0.0128	CbGeAlD
Cisplatin—GSTT1—head—muscle cancer	0.00035	0.0128	CbGeAlD
Cisplatin—ATP7A—bone marrow—muscle cancer	0.00035	0.0128	CbGeAlD
Cisplatin—ATP7A—Copper homeostasis—FOXO1—muscle cancer	0.000349	0.0172	CbGpPWpGaD
Cisplatin—MT2A—testis—muscle cancer	0.000345	0.0126	CbGeAlD
Cisplatin—SLC31A2—testis—muscle cancer	0.000339	0.0124	CbGeAlD
Cisplatin—ATP7A—vagina—muscle cancer	0.000335	0.0122	CbGeAlD
Cisplatin—SLC31A1—Copper homeostasis—FOXO1—muscle cancer	0.000335	0.0165	CbGpPWpGaD
Cisplatin—MT2A—Copper homeostasis—FOXO1—muscle cancer	0.000328	0.0162	CbGpPWpGaD
Cisplatin—MT1A—Copper homeostasis—MDM2—muscle cancer	0.000325	0.0161	CbGpPWpGaD
Cisplatin—GSTP1—embryo—muscle cancer	0.000319	0.0116	CbGeAlD
Cisplatin—SOD1—tendon—muscle cancer	0.000316	0.0115	CbGeAlD
Cisplatin—SLC31A1—tendon—muscle cancer	0.000308	0.0112	CbGeAlD
Cisplatin—SOD1—bone marrow—muscle cancer	0.000306	0.0112	CbGeAlD
Cisplatin—SLC22A2—renal system—muscle cancer	0.000305	0.0111	CbGeAlD
Cisplatin—ATP7A—testis—muscle cancer	0.000299	0.0109	CbGeAlD
Cisplatin—SLC31A1—bone marrow—muscle cancer	0.000298	0.0109	CbGeAlD
Cisplatin—SOD1—vagina—muscle cancer	0.000293	0.0107	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—MYOD1—muscle cancer	0.000293	0.0145	CbGpPWpGaD
Cisplatin—GSTM1—C-MYB transcription factor network—CD34—muscle cancer	0.000293	0.0145	CbGpPWpGaD
Cisplatin—SLC31A2—Copper homeostasis—TP53—muscle cancer	0.000289	0.0143	CbGpPWpGaD
Cisplatin—SLC31A1—vagina—muscle cancer	0.000286	0.0104	CbGeAlD
Cisplatin—ABCC6—head—muscle cancer	0.000284	0.0104	CbGeAlD
Cisplatin—XDH—vagina—muscle cancer	0.000282	0.0103	CbGeAlD
Cisplatin—NQO1—smooth muscle tissue—muscle cancer	0.00028	0.0102	CbGeAlD
Cisplatin—NQO1—renal system—muscle cancer	0.00027	0.00985	CbGeAlD
Cisplatin—SLC31A1—head—muscle cancer	0.000264	0.00963	CbGeAlD
Cisplatin—SOD1—testis—muscle cancer	0.000262	0.00955	CbGeAlD
Cisplatin—ABCC5—cardiac atrium—muscle cancer	0.000258	0.00943	CbGeAlD
Cisplatin—GSTM1—head—muscle cancer	0.000258	0.0094	CbGeAlD
Cisplatin—SLC31A1—testis—muscle cancer	0.000255	0.0093	CbGeAlD
Cisplatin—GSTP1—smooth muscle tissue—muscle cancer	0.000251	0.00914	CbGeAlD
Cisplatin—GSTM1—testis—muscle cancer	0.000249	0.00908	CbGeAlD
Cisplatin—MPO—C-MYB transcription factor network—MYOD1—muscle cancer	0.000249	0.0123	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—CD34—muscle cancer	0.000249	0.0123	CbGpPWpGaD
Cisplatin—MPO—renal system—muscle cancer	0.000248	0.00905	CbGeAlD
Cisplatin—ATP7B—Copper homeostasis—MDM2—muscle cancer	0.000246	0.0122	CbGpPWpGaD
Cisplatin—ABCC3—renal system—muscle cancer	0.000242	0.00884	CbGeAlD
Cisplatin—GSTP1—renal system—muscle cancer	0.000241	0.0088	CbGeAlD
Cisplatin—SOD1—AGE/RAGE pathway—FOXO4—muscle cancer	0.000235	0.0116	CbGpPWpGaD
Cisplatin—ABCC5—tendon—muscle cancer	0.000225	0.00821	CbGeAlD
Cisplatin—ABCC5—bone marrow—muscle cancer	0.000218	0.00796	CbGeAlD
Cisplatin—GSTP1—cardiac atrium—muscle cancer	0.000216	0.00788	CbGeAlD
Cisplatin—NQO1—tendon—muscle cancer	0.000211	0.00769	CbGeAlD
Cisplatin—SOD1—Copper homeostasis—FOXO1—muscle cancer	0.00021	0.0104	CbGpPWpGaD
Cisplatin—ATP7A—Copper homeostasis—MDM2—muscle cancer	0.000209	0.0104	CbGpPWpGaD
Cisplatin—ABCC5—vagina—muscle cancer	0.000209	0.00762	CbGeAlD
Cisplatin—PTGS2—C-MYB transcription factor network—MYF6—muscle cancer	0.000203	0.01	CbGpPWpGaD
Cisplatin—SLC31A1—Copper homeostasis—MDM2—muscle cancer	0.000201	0.00992	CbGpPWpGaD
Cisplatin—MT2A—Copper homeostasis—MDM2—muscle cancer	0.000197	0.00973	CbGpPWpGaD
Cisplatin—CYP4A11—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000196	0.00971	CbGpPWpGaD
Cisplatin—NQO1—vagina—muscle cancer	0.000195	0.00713	CbGeAlD
Cisplatin—ABCC2—renal system—muscle cancer	0.000194	0.00706	CbGeAlD
Cisplatin—GSTP1—tendon—muscle cancer	0.000188	0.00687	CbGeAlD
Cisplatin—MPO—bone marrow—muscle cancer	0.000188	0.00684	CbGeAlD
Cisplatin—ABCC5—testis—muscle cancer	0.000186	0.0068	CbGeAlD
Cisplatin—MT1A—Copper homeostasis—TP53—muscle cancer	0.000186	0.00922	CbGpPWpGaD
Cisplatin—GSTP1—bone marrow—muscle cancer	0.000182	0.00665	CbGeAlD
Cisplatin—NQO1—head—muscle cancer	0.000181	0.00659	CbGeAlD
Cisplatin—GSTP1—vagina—muscle cancer	0.000175	0.00637	CbGeAlD
Cisplatin—NQO1—testis—muscle cancer	0.000174	0.00636	CbGeAlD
Cisplatin—SOD1—AGE/RAGE pathway—FOXO1—muscle cancer	0.000174	0.00858	CbGpPWpGaD
Cisplatin—ABCC3—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000167	0.00826	CbGpPWpGaD
Cisplatin—MPO—head—muscle cancer	0.000166	0.00606	CbGeAlD
Cisplatin—ABCC3—head—muscle cancer	0.000162	0.00591	CbGeAlD
Cisplatin—SOD1—Platelet degranulation—IGF2—muscle cancer	0.000162	0.008	CbGpPWpGaD
Cisplatin—GSTP1—head—muscle cancer	0.000161	0.00589	CbGeAlD
Cisplatin—MPO—testis—muscle cancer	0.00016	0.00585	CbGeAlD
Cisplatin—MT2A—AP-1 transcription factor network—CDKN2A—muscle cancer	0.00016	0.00791	CbGpPWpGaD
Cisplatin—ABCC3—testis—muscle cancer	0.000157	0.00571	CbGeAlD
Cisplatin—GSTP1—testis—muscle cancer	0.000156	0.00569	CbGeAlD
Cisplatin—SOD1—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.000154	0.00762	CbGpPWpGaD
Cisplatin—BCHE—smooth muscle tissue—muscle cancer	0.000152	0.00553	CbGeAlD
Cisplatin—ABCC2—tendon—muscle cancer	0.000151	0.00551	CbGeAlD
Cisplatin—PTGS2—embryo—muscle cancer	0.000149	0.00542	CbGeAlD
Cisplatin—ATP7A—Cellular responses to stress—HMGA1—muscle cancer	0.000144	0.0071	CbGpPWpGaD
Cisplatin—ATP7B—Copper homeostasis—TP53—muscle cancer	0.000141	0.00699	CbGpPWpGaD
Cisplatin—CYP4A11—PPARA activates gene expression—MED12—muscle cancer	0.000133	0.00659	CbGpPWpGaD
Cisplatin—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	0.000132	0.00654	CbGpPWpGaD
Cisplatin—BCHE—cardiac atrium—muscle cancer	0.000131	0.00477	CbGeAlD
Cisplatin—CYP4A11—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—MED12—muscle cancer	0.00013	0.00645	CbGpPWpGaD
Cisplatin—CYP2B6—renal system—muscle cancer	0.00013	0.00475	CbGeAlD
Cisplatin—SOD1—Copper homeostasis—MDM2—muscle cancer	0.000126	0.00623	CbGpPWpGaD
Cisplatin—Hyperuricaemia—Methotrexate—muscle cancer	0.000126	0.00258	CcSEcCtD
Cisplatin—Flushing—Dactinomycin—muscle cancer	0.000125	0.00258	CcSEcCtD
Cisplatin—ABCC2—testis—muscle cancer	0.000125	0.00456	CbGeAlD
Cisplatin—Ageusia—Doxorubicin—muscle cancer	0.000124	0.00256	CcSEcCtD
Cisplatin—Dysarthria—Methotrexate—muscle cancer	0.000123	0.00254	CcSEcCtD
Cisplatin—Ulcer—Methotrexate—muscle cancer	0.000123	0.00254	CcSEcCtD
Cisplatin—ATP7A—Copper homeostasis—TP53—muscle cancer	0.00012	0.00594	CbGpPWpGaD
Cisplatin—Liver injury—Doxorubicin—muscle cancer	0.00012	0.00247	CcSEcCtD
Cisplatin—Alopecia—Dactinomycin—muscle cancer	0.000119	0.00245	CcSEcCtD
Cisplatin—Urinary tract disorder—Vincristine—muscle cancer	0.000119	0.00245	CcSEcCtD
Cisplatin—Sweating increased—Etoposide—muscle cancer	0.000119	0.00245	CcSEcCtD
Cisplatin—Blood uric acid increased—Methotrexate—muscle cancer	0.000119	0.00244	CcSEcCtD
Cisplatin—Connective tissue disorder—Vincristine—muscle cancer	0.000118	0.00244	CcSEcCtD
Cisplatin—Urethral disorder—Vincristine—muscle cancer	0.000118	0.00243	CcSEcCtD
Cisplatin—Erythema—Dactinomycin—muscle cancer	0.000117	0.00242	CcSEcCtD
Cisplatin—PTGS2—smooth muscle tissue—muscle cancer	0.000117	0.00426	CbGeAlD
Cisplatin—Pancytopenia—Etoposide—muscle cancer	0.000116	0.00239	CcSEcCtD
Cisplatin—Extravasation—Doxorubicin—muscle cancer	0.000116	0.00238	CcSEcCtD
Cisplatin—SLC31A1—Copper homeostasis—TP53—muscle cancer	0.000115	0.00569	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—PTGS2—muscle cancer	0.000114	0.00563	CbGpPWpGaD
Cisplatin—MT2A—Copper homeostasis—TP53—muscle cancer	0.000113	0.00558	CbGpPWpGaD
Cisplatin—PTGS2—renal system—muscle cancer	0.000113	0.00411	CbGeAlD
Cisplatin—GSTM1—C-MYB transcription factor network—KIT—muscle cancer	0.000112	0.00553	CbGpPWpGaD
Cisplatin—Cardiac disorder—Vincristine—muscle cancer	0.000112	0.0023	CcSEcCtD
Cisplatin—Skin exfoliation—Methotrexate—muscle cancer	0.000111	0.00229	CcSEcCtD
Cisplatin—Cellulitis—Doxorubicin—muscle cancer	0.000111	0.00228	CcSEcCtD
Cisplatin—BCHE—bone marrow—muscle cancer	0.00011	0.00403	CbGeAlD
Cisplatin—Ill-defined disorder—Dactinomycin—muscle cancer	0.000109	0.00224	CcSEcCtD
Cisplatin—Hyperuricaemia—Doxorubicin—muscle cancer	0.000109	0.00224	CcSEcCtD
Cisplatin—Mediastinal disorder—Vincristine—muscle cancer	0.000109	0.00224	CcSEcCtD
Cisplatin—Anaemia—Dactinomycin—muscle cancer	0.000109	0.00223	CcSEcCtD
Cisplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—CDKN2A—muscle cancer	0.000107	0.0053	CbGpPWpGaD
Cisplatin—Acute coronary syndrome—Etoposide—muscle cancer	0.000107	0.00221	CcSEcCtD
Cisplatin—Renal failure—Etoposide—muscle cancer	0.000107	0.0022	CcSEcCtD
Cisplatin—ABCG2—bone marrow—muscle cancer	0.000107	0.00389	CbGeAlD
Cisplatin—Dysarthria—Doxorubicin—muscle cancer	0.000107	0.0022	CcSEcCtD
Cisplatin—Ulcer—Doxorubicin—muscle cancer	0.000107	0.0022	CcSEcCtD
Cisplatin—Myocardial infarction—Etoposide—muscle cancer	0.000107	0.0022	CcSEcCtD
Cisplatin—Neuropathy peripheral—Etoposide—muscle cancer	0.000107	0.0022	CcSEcCtD
Cisplatin—Alopecia—Vincristine—muscle cancer	0.000106	0.00219	CcSEcCtD
Cisplatin—Stomatitis—Etoposide—muscle cancer	0.000106	0.00218	CcSEcCtD
Cisplatin—Malaise—Dactinomycin—muscle cancer	0.000106	0.00218	CcSEcCtD
Cisplatin—BCHE—vagina—muscle cancer	0.000106	0.00386	CbGeAlD
Cisplatin—Leukopenia—Dactinomycin—muscle cancer	0.000105	0.00216	CcSEcCtD
Cisplatin—NQO1—Validated transcriptional targets of TAp63 isoforms—MDM2—muscle cancer	0.000104	0.00514	CbGpPWpGaD
Cisplatin—Hepatobiliary disease—Etoposide—muscle cancer	0.000103	0.00212	CcSEcCtD
Cisplatin—Blood uric acid increased—Doxorubicin—muscle cancer	0.000103	0.00211	CcSEcCtD
Cisplatin—ABCG2—vagina—muscle cancer	0.000102	0.00373	CbGeAlD
Cisplatin—Hiccups—Doxorubicin—muscle cancer	0.000101	0.00208	CcSEcCtD
Cisplatin—Hepatocellular injury—Doxorubicin—muscle cancer	0.000101	0.00208	CcSEcCtD
Cisplatin—Myalgia—Dactinomycin—muscle cancer	0.0001	0.00206	CcSEcCtD
Cisplatin—Hyperkalaemia—Doxorubicin—muscle cancer	9.91e-05	0.00204	CcSEcCtD
Cisplatin—Discomfort—Dactinomycin—muscle cancer	9.88e-05	0.00203	CcSEcCtD
Cisplatin—BCHE—head—muscle cancer	9.77e-05	0.00356	CbGeAlD
Cisplatin—Anaemia—Vincristine—muscle cancer	9.7e-05	0.002	CcSEcCtD
Cisplatin—Urinary tract disorder—Etoposide—muscle cancer	9.64e-05	0.00199	CcSEcCtD
Cisplatin—Polyuria—Methotrexate—muscle cancer	9.63e-05	0.00198	CcSEcCtD
Cisplatin—Skin exfoliation—Doxorubicin—muscle cancer	9.63e-05	0.00198	CcSEcCtD
Cisplatin—Oedema—Dactinomycin—muscle cancer	9.58e-05	0.00197	CcSEcCtD
Cisplatin—Fluid retention—Doxorubicin—muscle cancer	9.57e-05	0.00197	CcSEcCtD
Cisplatin—Urethral disorder—Etoposide—muscle cancer	9.57e-05	0.00197	CcSEcCtD
Cisplatin—Infection—Dactinomycin—muscle cancer	9.52e-05	0.00196	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—KIT—muscle cancer	9.52e-05	0.0047	CbGpPWpGaD
Cisplatin—Neuropathy—Doxorubicin—muscle cancer	9.47e-05	0.00195	CcSEcCtD
Cisplatin—BCHE—testis—muscle cancer	9.44e-05	0.00344	CbGeAlD
Cisplatin—CYP2B6—vagina—muscle cancer	9.43e-05	0.00344	CbGeAlD
Cisplatin—Leukopenia—Vincristine—muscle cancer	9.39e-05	0.00193	CcSEcCtD
Cisplatin—Thrombocytopenia—Dactinomycin—muscle cancer	9.38e-05	0.00193	CcSEcCtD
Cisplatin—SOD1—Amyotrophic lateral sclerosis (ALS)—TP53—muscle cancer	9.3e-05	0.0046	CbGpPWpGaD
Cisplatin—ABCB1—embryo—muscle cancer	9.19e-05	0.00335	CbGeAlD
Cisplatin—Renal failure acute—Methotrexate—muscle cancer	9.15e-05	0.00189	CcSEcCtD
Cisplatin—Anorexia—Dactinomycin—muscle cancer	9.13e-05	0.00188	CcSEcCtD
Cisplatin—Eye disorder—Etoposide—muscle cancer	9.12e-05	0.00188	CcSEcCtD
Cisplatin—ABCG2—testis—muscle cancer	9.12e-05	0.00333	CbGeAlD
Cisplatin—Convulsion—Vincristine—muscle cancer	9.09e-05	0.00187	CcSEcCtD
Cisplatin—GSTM1—C-MYB transcription factor network—CDKN2A—muscle cancer	9.09e-05	0.00449	CbGpPWpGaD
Cisplatin—Flushing—Etoposide—muscle cancer	9.06e-05	0.00187	CcSEcCtD
Cisplatin—Cardiac disorder—Etoposide—muscle cancer	9.06e-05	0.00187	CcSEcCtD
Cisplatin—CYP4A11—Fatty acid, triacylglycerol, and ketone body metabolism—MED12—muscle cancer	8.98e-05	0.00444	CbGpPWpGaD
Cisplatin—NQO1—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	8.98e-05	0.00444	CbGpPWpGaD
Cisplatin—Myalgia—Vincristine—muscle cancer	8.93e-05	0.00184	CcSEcCtD
Cisplatin—MT2A—AP-1 transcription factor network—TP53—muscle cancer	8.9e-05	0.0044	CbGpPWpGaD
Cisplatin—Immune system disorder—Etoposide—muscle cancer	8.82e-05	0.00182	CcSEcCtD
Cisplatin—Mediastinal disorder—Etoposide—muscle cancer	8.8e-05	0.00181	CcSEcCtD
Cisplatin—PTGS2—tendon—muscle cancer	8.78e-05	0.0032	CbGeAlD
Cisplatin—Anaphylactoid reaction—Methotrexate—muscle cancer	8.73e-05	0.0018	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Dactinomycin—muscle cancer	8.73e-05	0.0018	CcSEcCtD
Cisplatin—CYP2B6—head—muscle cancer	8.71e-05	0.00318	CbGeAlD
Cisplatin—SOD1—Cellular responses to stress—HMGA1—muscle cancer	8.64e-05	0.00427	CbGpPWpGaD
Cisplatin—Alopecia—Etoposide—muscle cancer	8.63e-05	0.00178	CcSEcCtD
Cisplatin—Cerebrovascular accident—Methotrexate—muscle cancer	8.63e-05	0.00178	CcSEcCtD
Cisplatin—Anaphylactic shock—Vincristine—muscle cancer	8.56e-05	0.00176	CcSEcCtD
Cisplatin—Oedema—Vincristine—muscle cancer	8.56e-05	0.00176	CcSEcCtD
Cisplatin—PTGS2—bone marrow—muscle cancer	8.51e-05	0.0031	CbGeAlD
Cisplatin—Infection—Vincristine—muscle cancer	8.51e-05	0.00175	CcSEcCtD
Cisplatin—GSTM1—C-MYB transcription factor network—PTGS2—muscle cancer	8.5e-05	0.0042	CbGpPWpGaD
Cisplatin—Phlebitis—Doxorubicin—muscle cancer	8.5e-05	0.00175	CcSEcCtD
Cisplatin—CYP2B6—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	8.44e-05	0.00417	CbGpPWpGaD
Cisplatin—CYP2B6—testis—muscle cancer	8.42e-05	0.00307	CbGeAlD
Cisplatin—Nervous system disorder—Vincristine—muscle cancer	8.4e-05	0.00173	CcSEcCtD
Cisplatin—Thrombocytopenia—Vincristine—muscle cancer	8.38e-05	0.00173	CcSEcCtD
Cisplatin—Decreased appetite—Dactinomycin—muscle cancer	8.33e-05	0.00172	CcSEcCtD
Cisplatin—Hyperhidrosis—Vincristine—muscle cancer	8.28e-05	0.0017	CcSEcCtD
Cisplatin—Pain—Dactinomycin—muscle cancer	8.19e-05	0.00169	CcSEcCtD
Cisplatin—Muscle spasms—Etoposide—muscle cancer	8.17e-05	0.00168	CcSEcCtD
Cisplatin—Anorexia—Vincristine—muscle cancer	8.16e-05	0.00168	CcSEcCtD
Cisplatin—PTGS2—vagina—muscle cancer	8.15e-05	0.00297	CbGeAlD
Cisplatin—PTGS2—C-MYB transcription factor network—CD34—muscle cancer	8.08e-05	0.004	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—MYOD1—muscle cancer	8.08e-05	0.004	CbGpPWpGaD
Cisplatin—Cardiac failure congestive—Doxorubicin—muscle cancer	8.07e-05	0.00166	CcSEcCtD
Cisplatin—Irritability—Methotrexate—muscle cancer	8.07e-05	0.00166	CcSEcCtD
Cisplatin—Hypotension—Vincristine—muscle cancer	8e-05	0.00165	CcSEcCtD
Cisplatin—SOD1—Selenium Micronutrient Network—PTGS2—muscle cancer	7.98e-05	0.00394	CbGpPWpGaD
Cisplatin—CYP4A11—Arachidonic acid metabolism—PTGS2—muscle cancer	7.95e-05	0.00393	CbGpPWpGaD
Cisplatin—Renal failure acute—Doxorubicin—muscle cancer	7.93e-05	0.00163	CcSEcCtD
Cisplatin—Feeling abnormal—Dactinomycin—muscle cancer	7.9e-05	0.00163	CcSEcCtD
Cisplatin—Ill-defined disorder—Etoposide—muscle cancer	7.88e-05	0.00162	CcSEcCtD
Cisplatin—Anaemia—Etoposide—muscle cancer	7.85e-05	0.00162	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Vincristine—muscle cancer	7.8e-05	0.00161	CcSEcCtD
Cisplatin—MPO—C-MYB transcription factor network—CDKN2A—muscle cancer	7.73e-05	0.00382	CbGpPWpGaD
Cisplatin—Paraesthesia—Vincristine—muscle cancer	7.69e-05	0.00158	CcSEcCtD
Cisplatin—Malaise—Etoposide—muscle cancer	7.66e-05	0.00158	CcSEcCtD
Cisplatin—Breast disorder—Methotrexate—muscle cancer	7.64e-05	0.00157	CcSEcCtD
Cisplatin—ABCC5—Fluoropyrimidine Activity—TP53—muscle cancer	7.61e-05	0.00376	CbGpPWpGaD
Cisplatin—Leukopenia—Etoposide—muscle cancer	7.61e-05	0.00157	CcSEcCtD
Cisplatin—SOD1—Hemostasis—ANGPT2—muscle cancer	7.6e-05	0.00376	CbGpPWpGaD
Cisplatin—Body temperature increased—Dactinomycin—muscle cancer	7.58e-05	0.00156	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—muscle cancer	7.56e-05	0.00156	CcSEcCtD
Cisplatin—GSTP1—Cellular responses to stress—HMGA1—muscle cancer	7.54e-05	0.00373	CbGpPWpGaD
Cisplatin—PTGS2—head—muscle cancer	7.53e-05	0.00275	CbGeAlD
Cisplatin—Cerebrovascular accident—Doxorubicin—muscle cancer	7.47e-05	0.00154	CcSEcCtD
Cisplatin—Decreased appetite—Vincristine—muscle cancer	7.44e-05	0.00153	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Vincristine—muscle cancer	7.39e-05	0.00152	CcSEcCtD
Cisplatin—Convulsion—Etoposide—muscle cancer	7.36e-05	0.00152	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—muscle cancer	7.35e-05	0.00151	CcSEcCtD
Cisplatin—Pain—Vincristine—muscle cancer	7.32e-05	0.00151	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	7.32e-05	0.00151	CcSEcCtD
Cisplatin—BCHE—Metabolism of proteins—TIMM10—muscle cancer	7.28e-05	0.0036	CbGpPWpGaD
Cisplatin—SOD1—Copper homeostasis—TP53—muscle cancer	7.23e-05	0.00358	CbGpPWpGaD
Cisplatin—MPO—C-MYB transcription factor network—PTGS2—muscle cancer	7.22e-05	0.00357	CbGpPWpGaD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	7.18e-05	0.00148	CcSEcCtD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—IGF2—muscle cancer	7.17e-05	0.00355	CbGpPWpGaD
Cisplatin—Pancreatitis—Methotrexate—muscle cancer	7.16e-05	0.00147	CcSEcCtD
Cisplatin—Discomfort—Etoposide—muscle cancer	7.15e-05	0.00147	CcSEcCtD
Cisplatin—GSTT1—Metabolism—FH—muscle cancer	7.08e-05	0.0035	CbGpPWpGaD
Cisplatin—Face oedema—Doxorubicin—muscle cancer	7.07e-05	0.00146	CcSEcCtD
Cisplatin—ABCC5—Carbohydrate metabolism—ENO2—muscle cancer	7.06e-05	0.00349	CbGpPWpGaD
Cisplatin—Hypersensitivity—Dactinomycin—muscle cancer	7.06e-05	0.00145	CcSEcCtD
Cisplatin—Abdominal discomfort—Methotrexate—muscle cancer	7e-05	0.00144	CcSEcCtD
Cisplatin—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—muscle cancer	6.97e-05	0.00344	CbGpPWpGaD
Cisplatin—MPO—Selenium Micronutrient Network—PTGS2—muscle cancer	6.96e-05	0.00344	CbGpPWpGaD
Cisplatin—ABCB1—renal system—muscle cancer	6.96e-05	0.00254	CbGeAlD
Cisplatin—Pancytopenia—Methotrexate—muscle cancer	6.94e-05	0.00143	CcSEcCtD
Cisplatin—Anaphylactic shock—Etoposide—muscle cancer	6.94e-05	0.00143	CcSEcCtD
Cisplatin—Infection—Etoposide—muscle cancer	6.89e-05	0.00142	CcSEcCtD
Cisplatin—Asthenia—Dactinomycin—muscle cancer	6.88e-05	0.00142	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—muscle cancer	6.86e-05	0.00141	CcSEcCtD
Cisplatin—Dehydration—Doxorubicin—muscle cancer	6.81e-05	0.0014	CcSEcCtD
Cisplatin—Thrombocytopenia—Etoposide—muscle cancer	6.79e-05	0.0014	CcSEcCtD
Cisplatin—SOD1—Platelet degranulation—VEGFA—muscle cancer	6.78e-05	0.00335	CbGpPWpGaD
Cisplatin—Tachycardia—Etoposide—muscle cancer	6.77e-05	0.00139	CcSEcCtD
Cisplatin—Body temperature increased—Vincristine—muscle cancer	6.77e-05	0.00139	CcSEcCtD
Cisplatin—Skin disorder—Etoposide—muscle cancer	6.74e-05	0.00139	CcSEcCtD
Cisplatin—Hyperhidrosis—Etoposide—muscle cancer	6.7e-05	0.00138	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—muscle cancer	6.68e-05	0.00138	CcSEcCtD
Cisplatin—Hypokalaemia—Doxorubicin—muscle cancer	6.66e-05	0.00137	CcSEcCtD
Cisplatin—Breast disorder—Doxorubicin—muscle cancer	6.61e-05	0.00136	CcSEcCtD
Cisplatin—Anorexia—Etoposide—muscle cancer	6.61e-05	0.00136	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—muscle cancer	6.59e-05	0.00136	CcSEcCtD
Cisplatin—Diarrhoea—Dactinomycin—muscle cancer	6.56e-05	0.00135	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—muscle cancer	6.54e-05	0.00135	CcSEcCtD
Cisplatin—Hypotension—Etoposide—muscle cancer	6.48e-05	0.00133	CcSEcCtD
Cisplatin—SOD1—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	6.46e-05	0.00319	CbGpPWpGaD
Cisplatin—Renal failure—Methotrexate—muscle cancer	6.4e-05	0.00132	CcSEcCtD
Cisplatin—Stomatitis—Methotrexate—muscle cancer	6.35e-05	0.00131	CcSEcCtD
Cisplatin—Conjunctivitis—Methotrexate—muscle cancer	6.33e-05	0.0013	CcSEcCtD
Cisplatin—Hypersensitivity—Vincristine—muscle cancer	6.31e-05	0.0013	CcSEcCtD
Cisplatin—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	6.24e-05	0.00308	CbGpPWpGaD
Cisplatin—Paraesthesia—Etoposide—muscle cancer	6.23e-05	0.00128	CcSEcCtD
Cisplatin—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	6.22e-05	0.00308	CbGpPWpGaD
Cisplatin—Pancreatitis—Doxorubicin—muscle cancer	6.2e-05	0.00128	CcSEcCtD
Cisplatin—Dyspnoea—Etoposide—muscle cancer	6.18e-05	0.00127	CcSEcCtD
Cisplatin—Hepatobiliary disease—Methotrexate—muscle cancer	6.16e-05	0.00127	CcSEcCtD
Cisplatin—Asthenia—Vincristine—muscle cancer	6.14e-05	0.00127	CcSEcCtD
Cisplatin—Vomiting—Dactinomycin—muscle cancer	6.09e-05	0.00125	CcSEcCtD
Cisplatin—XDH—Selenium Micronutrient Network—PTGS2—muscle cancer	6.08e-05	0.00301	CbGpPWpGaD
Cisplatin—PTGS2—S1P1 pathway—VEGFA—muscle cancer	6.07e-05	0.003	CbGpPWpGaD
Cisplatin—Rash—Dactinomycin—muscle cancer	6.04e-05	0.00124	CcSEcCtD
Cisplatin—Decreased appetite—Etoposide—muscle cancer	6.03e-05	0.00124	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—muscle cancer	6.01e-05	0.00124	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Etoposide—muscle cancer	5.99e-05	0.00123	CcSEcCtD
Cisplatin—SOD1—Folate Metabolism—TP53—muscle cancer	5.98e-05	0.00295	CbGpPWpGaD
Cisplatin—Pain—Etoposide—muscle cancer	5.93e-05	0.00122	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—CDKN2A—muscle cancer	5.88e-05	0.00291	CbGpPWpGaD
Cisplatin—Diarrhoea—Vincristine—muscle cancer	5.86e-05	0.00121	CcSEcCtD
Cisplatin—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—muscle cancer	5.81e-05	0.00287	CbGpPWpGaD
Cisplatin—Urinary tract disorder—Methotrexate—muscle cancer	5.77e-05	0.00119	CcSEcCtD
Cisplatin—Urethral disorder—Methotrexate—muscle cancer	5.73e-05	0.00118	CcSEcCtD
Cisplatin—Feeling abnormal—Etoposide—muscle cancer	5.72e-05	0.00118	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—MDM2—muscle cancer	5.71e-05	0.00282	CbGpPWpGaD
Cisplatin—Nausea—Dactinomycin—muscle cancer	5.69e-05	0.00117	CcSEcCtD
Cisplatin—Visual impairment—Methotrexate—muscle cancer	5.63e-05	0.00116	CcSEcCtD
Cisplatin—ABCC3—Fluoropyrimidine Activity—TP53—muscle cancer	5.61e-05	0.00277	CbGpPWpGaD
Cisplatin—MT2A—Immune System—CD34—muscle cancer	5.55e-05	0.00274	CbGpPWpGaD
Cisplatin—Renal failure—Doxorubicin—muscle cancer	5.54e-05	0.00114	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—muscle cancer	5.53e-05	0.00114	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—muscle cancer	5.5e-05	0.00113	CcSEcCtD
Cisplatin—Body temperature increased—Etoposide—muscle cancer	5.48e-05	0.00113	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—muscle cancer	5.48e-05	0.00113	CcSEcCtD
Cisplatin—Eye disorder—Methotrexate—muscle cancer	5.46e-05	0.00113	CcSEcCtD
Cisplatin—Tinnitus—Methotrexate—muscle cancer	5.45e-05	0.00112	CcSEcCtD
Cisplatin—Vomiting—Vincristine—muscle cancer	5.44e-05	0.00112	CcSEcCtD
Cisplatin—Cardiac disorder—Methotrexate—muscle cancer	5.43e-05	0.00112	CcSEcCtD
Cisplatin—Rash—Vincristine—muscle cancer	5.4e-05	0.00111	CcSEcCtD
Cisplatin—Dermatitis—Vincristine—muscle cancer	5.39e-05	0.00111	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—muscle cancer	5.33e-05	0.0011	CcSEcCtD
Cisplatin—Immune system disorder—Methotrexate—muscle cancer	5.28e-05	0.00109	CcSEcCtD
Cisplatin—Mediastinal disorder—Methotrexate—muscle cancer	5.27e-05	0.00109	CcSEcCtD
Cisplatin—ABCB1—bone marrow—muscle cancer	5.26e-05	0.00192	CbGeAlD
Cisplatin—MPO—Folate Metabolism—TP53—muscle cancer	5.21e-05	0.00258	CbGpPWpGaD
Cisplatin—Alopecia—Methotrexate—muscle cancer	5.17e-05	0.00106	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—muscle cancer	5.15e-05	0.00106	CcSEcCtD
Cisplatin—Hypersensitivity—Etoposide—muscle cancer	5.11e-05	0.00105	CcSEcCtD
Cisplatin—Malnutrition—Methotrexate—muscle cancer	5.09e-05	0.00105	CcSEcCtD
Cisplatin—Erythema—Methotrexate—muscle cancer	5.09e-05	0.00105	CcSEcCtD
Cisplatin—Nausea—Vincristine—muscle cancer	5.09e-05	0.00105	CcSEcCtD
Cisplatin—ABCB1—vagina—muscle cancer	5.04e-05	0.00184	CbGeAlD
Cisplatin—Urinary tract disorder—Doxorubicin—muscle cancer	5e-05	0.00103	CcSEcCtD
Cisplatin—ABCG2—HIF-2-alpha transcription factor network—VEGFA—muscle cancer	5e-05	0.00247	CbGpPWpGaD
Cisplatin—Asthenia—Etoposide—muscle cancer	4.98e-05	0.00102	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—muscle cancer	4.98e-05	0.00102	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—muscle cancer	4.96e-05	0.00102	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—muscle cancer	4.88e-05	0.001	CcSEcCtD
Cisplatin—Vision blurred—Methotrexate—muscle cancer	4.8e-05	0.000988	CcSEcCtD
Cisplatin—Diarrhoea—Etoposide—muscle cancer	4.75e-05	0.000977	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—muscle cancer	4.73e-05	0.000974	CcSEcCtD
Cisplatin—Ill-defined disorder—Methotrexate—muscle cancer	4.72e-05	0.000973	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—muscle cancer	4.72e-05	0.000972	CcSEcCtD
Cisplatin—Anaemia—Methotrexate—muscle cancer	4.7e-05	0.000969	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—muscle cancer	4.7e-05	0.000968	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—muscle cancer	4.7e-05	0.000968	CcSEcCtD
Cisplatin—ABCB1—head—muscle cancer	4.66e-05	0.0017	CbGeAlD
Cisplatin—Malaise—Methotrexate—muscle cancer	4.59e-05	0.000945	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—muscle cancer	4.57e-05	0.000942	CcSEcCtD
Cisplatin—GSTM1—Metabolism—FH—muscle cancer	4.56e-05	0.00226	CbGpPWpGaD
Cisplatin—Mediastinal disorder—Doxorubicin—muscle cancer	4.56e-05	0.00094	CcSEcCtD
Cisplatin—Leukopenia—Methotrexate—muscle cancer	4.56e-05	0.000938	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—muscle cancer	4.52e-05	0.000931	CcSEcCtD
Cisplatin—ABCB1—testis—muscle cancer	4.5e-05	0.00164	CbGeAlD
Cisplatin—Alopecia—Doxorubicin—muscle cancer	4.47e-05	0.000921	CcSEcCtD
Cisplatin—Convulsion—Methotrexate—muscle cancer	4.41e-05	0.000908	CcSEcCtD
Cisplatin—Vomiting—Etoposide—muscle cancer	4.41e-05	0.000908	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—muscle cancer	4.41e-05	0.000908	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—muscle cancer	4.41e-05	0.000908	CcSEcCtD
Cisplatin—Rash—Etoposide—muscle cancer	4.37e-05	0.000901	CcSEcCtD
Cisplatin—Dermatitis—Etoposide—muscle cancer	4.37e-05	0.0009	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—muscle cancer	4.34e-05	0.000894	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—VEGFA—muscle cancer	4.33e-05	0.00214	CbGpPWpGaD
Cisplatin—Myalgia—Methotrexate—muscle cancer	4.33e-05	0.000892	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	4.3e-05	0.000886	CcSEcCtD
Cisplatin—Discomfort—Methotrexate—muscle cancer	4.28e-05	0.000882	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—muscle cancer	4.24e-05	0.000873	CcSEcCtD
Cisplatin—Anaphylactic shock—Methotrexate—muscle cancer	4.15e-05	0.000856	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—muscle cancer	4.15e-05	0.000855	CcSEcCtD
Cisplatin—Infection—Methotrexate—muscle cancer	4.13e-05	0.00085	CcSEcCtD
Cisplatin—Nausea—Etoposide—muscle cancer	4.12e-05	0.000848	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—muscle cancer	4.09e-05	0.000842	CcSEcCtD
Cisplatin—Nervous system disorder—Methotrexate—muscle cancer	4.07e-05	0.000839	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—muscle cancer	4.07e-05	0.000839	CcSEcCtD
Cisplatin—Thrombocytopenia—Methotrexate—muscle cancer	4.07e-05	0.000838	CcSEcCtD
Cisplatin—Skin disorder—Methotrexate—muscle cancer	4.04e-05	0.000831	CcSEcCtD
Cisplatin—Hyperhidrosis—Methotrexate—muscle cancer	4.02e-05	0.000827	CcSEcCtD
Cisplatin—GSTT1—Metabolism—MED12—muscle cancer	4e-05	0.00198	CbGpPWpGaD
Cisplatin—Malaise—Doxorubicin—muscle cancer	3.97e-05	0.000819	CcSEcCtD
Cisplatin—Anorexia—Methotrexate—muscle cancer	3.96e-05	0.000815	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—muscle cancer	3.95e-05	0.000812	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	3.89e-05	0.00193	CbGpPWpGaD
Cisplatin—Hypotension—Methotrexate—muscle cancer	3.88e-05	0.000799	CcSEcCtD
Cisplatin—GSTP1—Metabolism—FH—muscle cancer	3.88e-05	0.00192	CbGpPWpGaD
Cisplatin—ABCG2—Fluoropyrimidine Activity—TP53—muscle cancer	3.87e-05	0.00191	CbGpPWpGaD
Cisplatin—Convulsion—Doxorubicin—muscle cancer	3.82e-05	0.000786	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Methotrexate—muscle cancer	3.78e-05	0.000779	CcSEcCtD
Cisplatin—NQO1—Metabolism—FH—muscle cancer	3.78e-05	0.00187	CbGpPWpGaD
Cisplatin—MT2A—Immune System—FOXO4—muscle cancer	3.77e-05	0.00187	CbGpPWpGaD
Cisplatin—Myalgia—Doxorubicin—muscle cancer	3.75e-05	0.000773	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—muscle cancer	3.74e-05	0.00077	CcSEcCtD
Cisplatin—Paraesthesia—Methotrexate—muscle cancer	3.73e-05	0.000768	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	3.73e-05	0.000767	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—muscle cancer	3.71e-05	0.000763	CcSEcCtD
Cisplatin—Dyspnoea—Methotrexate—muscle cancer	3.7e-05	0.000763	CcSEcCtD
Cisplatin—SOD1—Hemostasis—IGF2—muscle cancer	3.7e-05	0.00183	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—ENO2—muscle cancer	3.65e-05	0.0018	CbGpPWpGaD
Cisplatin—Decreased appetite—Methotrexate—muscle cancer	3.61e-05	0.000744	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—muscle cancer	3.6e-05	0.000741	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—muscle cancer	3.6e-05	0.000741	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Methotrexate—muscle cancer	3.59e-05	0.000739	CcSEcCtD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.58e-05	0.00177	CbGpPWpGaD
Cisplatin—Infection—Doxorubicin—muscle cancer	3.57e-05	0.000736	CcSEcCtD
Cisplatin—Pain—Methotrexate—muscle cancer	3.55e-05	0.000732	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—CDKN2A—muscle cancer	3.54e-05	0.00175	CbGpPWpGaD
Cisplatin—Nervous system disorder—Doxorubicin—muscle cancer	3.53e-05	0.000726	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—muscle cancer	3.52e-05	0.000725	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—muscle cancer	3.51e-05	0.000723	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—muscle cancer	3.49e-05	0.00072	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—muscle cancer	3.48e-05	0.000716	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—MDM2—muscle cancer	3.44e-05	0.0017	CbGpPWpGaD
Cisplatin—Anorexia—Doxorubicin—muscle cancer	3.43e-05	0.000706	CcSEcCtD
Cisplatin—Feeling abnormal—Methotrexate—muscle cancer	3.42e-05	0.000705	CcSEcCtD
Cisplatin—XDH—Metabolism—FH—muscle cancer	3.39e-05	0.00168	CbGpPWpGaD
Cisplatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—muscle cancer	3.37e-05	0.00167	CbGpPWpGaD
Cisplatin—Hypotension—Doxorubicin—muscle cancer	3.36e-05	0.000692	CcSEcCtD
Cisplatin—Body temperature increased—Methotrexate—muscle cancer	3.28e-05	0.000676	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—muscle cancer	3.28e-05	0.000675	CcSEcCtD
Cisplatin—ATP7A—Cellular responses to stress—TP53—muscle cancer	3.27e-05	0.00162	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—FH—muscle cancer	3.25e-05	0.00161	CbGpPWpGaD
Cisplatin—Paraesthesia—Doxorubicin—muscle cancer	3.23e-05	0.000665	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—muscle cancer	3.21e-05	0.00066	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—muscle cancer	3.13e-05	0.000644	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—muscle cancer	3.11e-05	0.00064	CcSEcCtD
Cisplatin—PTGS2—C-MYB transcription factor network—KIT—muscle cancer	3.09e-05	0.00153	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—CDKN2A—muscle cancer	3.09e-05	0.00153	CbGpPWpGaD
Cisplatin—Pain—Doxorubicin—muscle cancer	3.08e-05	0.000633	CcSEcCtD
Cisplatin—Hypersensitivity—Methotrexate—muscle cancer	3.06e-05	0.00063	CcSEcCtD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—MED12—muscle cancer	3.04e-05	0.0015	CbGpPWpGaD
Cisplatin—SOD1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	3.01e-05	0.00149	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—MDM2—muscle cancer	3e-05	0.00148	CbGpPWpGaD
Cisplatin—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—muscle cancer	2.99e-05	0.00148	CbGpPWpGaD
Cisplatin—Asthenia—Methotrexate—muscle cancer	2.98e-05	0.000614	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—muscle cancer	2.96e-05	0.00061	CcSEcCtD
Cisplatin—ABCG2—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	2.94e-05	0.00145	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	2.85e-05	0.00141	CbGpPWpGaD
Cisplatin—Body temperature increased—Doxorubicin—muscle cancer	2.84e-05	0.000586	CcSEcCtD
Cisplatin—Diarrhoea—Methotrexate—muscle cancer	2.84e-05	0.000585	CcSEcCtD
Cisplatin—CYP4A11—Metabolism—FH—muscle cancer	2.82e-05	0.00139	CbGpPWpGaD
Cisplatin—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—muscle cancer	2.81e-05	0.00139	CbGpPWpGaD
Cisplatin—MT2A—Immune System—FOXO1—muscle cancer	2.79e-05	0.00138	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—muscle cancer	2.76e-05	0.00136	CbGpPWpGaD
Cisplatin—Hypersensitivity—Doxorubicin—muscle cancer	2.65e-05	0.000546	CcSEcCtD
Cisplatin—Vomiting—Methotrexate—muscle cancer	2.64e-05	0.000544	CcSEcCtD
Cisplatin—Rash—Methotrexate—muscle cancer	2.62e-05	0.000539	CcSEcCtD
Cisplatin—Dermatitis—Methotrexate—muscle cancer	2.62e-05	0.000539	CcSEcCtD
Cisplatin—SOD1—Cellular responses to stress—VEGFA—muscle cancer	2.61e-05	0.00129	CbGpPWpGaD
Cisplatin—Asthenia—Doxorubicin—muscle cancer	2.58e-05	0.000531	CcSEcCtD
Cisplatin—GSTM1—Metabolism—MED12—muscle cancer	2.58e-05	0.00128	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—CDKN2A—muscle cancer	2.51e-05	0.00124	CbGpPWpGaD
Cisplatin—Nausea—Methotrexate—muscle cancer	2.47e-05	0.000508	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—muscle cancer	2.46e-05	0.000507	CcSEcCtD
Cisplatin—ABCC3—Metabolism—FH—muscle cancer	2.4e-05	0.00119	CbGpPWpGaD
Cisplatin—CYP2C9—Arachidonic acid metabolism—PTGS2—muscle cancer	2.35e-05	0.00116	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—ENO2—muscle cancer	2.35e-05	0.00116	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—MED12—muscle cancer	2.32e-05	0.00115	CbGpPWpGaD
Cisplatin—Vomiting—Doxorubicin—muscle cancer	2.29e-05	0.000471	CcSEcCtD
Cisplatin—GSTP1—Cellular responses to stress—VEGFA—muscle cancer	2.28e-05	0.00113	CbGpPWpGaD
Cisplatin—Rash—Doxorubicin—muscle cancer	2.27e-05	0.000467	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—muscle cancer	2.27e-05	0.000467	CcSEcCtD
Cisplatin—GSTP1—Metabolism—MED12—muscle cancer	2.19e-05	0.00108	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—MED12—muscle cancer	2.14e-05	0.00106	CbGpPWpGaD
Cisplatin—Nausea—Doxorubicin—muscle cancer	2.14e-05	0.00044	CcSEcCtD
Cisplatin—MT2A—Immune System—KIT—muscle cancer	2.12e-05	0.00105	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—muscle cancer	2.02e-05	0.000998	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ENO2—muscle cancer	2e-05	0.000989	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—ENO2—muscle cancer	2e-05	0.000988	CbGpPWpGaD
Cisplatin—SOD1—Cellular responses to stress—TP53—muscle cancer	1.97e-05	0.000975	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—ENO2—muscle cancer	1.95e-05	0.000963	CbGpPWpGaD
Cisplatin—XDH—Metabolism—MED12—muscle cancer	1.92e-05	0.000948	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—MED12—muscle cancer	1.84e-05	0.000909	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—FH—muscle cancer	1.83e-05	0.000906	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HMGA1—muscle cancer	1.82e-05	0.000899	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—MDM2—muscle cancer	1.77e-05	0.000874	CbGpPWpGaD
Cisplatin—XDH—Metabolism—ENO2—muscle cancer	1.75e-05	0.000864	CbGpPWpGaD
Cisplatin—GSTP1—Cellular responses to stress—TP53—muscle cancer	1.72e-05	0.00085	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—ENO2—muscle cancer	1.68e-05	0.000828	CbGpPWpGaD
Cisplatin—MT2A—Immune System—MDM2—muscle cancer	1.67e-05	0.000827	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—FH—muscle cancer	1.65e-05	0.000817	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—FH—muscle cancer	1.64e-05	0.000809	CbGpPWpGaD
Cisplatin—ABCC5—Disease—FOXO4—muscle cancer	1.63e-05	0.000806	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.6e-05	0.000791	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—MED12—muscle cancer	1.59e-05	0.000788	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—muscle cancer	1.59e-05	0.000786	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—MDM2—muscle cancer	1.58e-05	0.00078	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—VEGFA—muscle cancer	1.55e-05	0.000767	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—ENO2—muscle cancer	1.45e-05	0.000718	CbGpPWpGaD
Cisplatin—ABCB1—Allograft Rejection—VEGFA—muscle cancer	1.38e-05	0.000681	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—MED12—muscle cancer	1.35e-05	0.00067	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—MDM2—muscle cancer	1.35e-05	0.000669	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTGS2—muscle cancer	1.27e-05	0.000628	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	1.26e-05	0.000624	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—FH—muscle cancer	1.26e-05	0.000623	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ENO2—muscle cancer	1.24e-05	0.000611	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—FH—muscle cancer	1.21e-05	0.000599	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—MDM2—muscle cancer	1.21e-05	0.000598	CbGpPWpGaD
Cisplatin—ABCC5—Disease—FOXO1—muscle cancer	1.2e-05	0.000596	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—IGF2—muscle cancer	1.2e-05	0.000592	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—muscle cancer	1.17e-05	0.000579	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	1.14e-05	0.000562	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—muscle cancer	1.06e-05	0.000526	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—MED12—muscle cancer	1.06e-05	0.000524	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—MED12—muscle cancer	1.04e-05	0.000512	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	9.66e-06	0.000478	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	9.58e-06	0.000474	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ENO2—muscle cancer	9.44e-06	0.000467	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MED12—muscle cancer	9.34e-06	0.000462	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MED12—muscle cancer	9.25e-06	0.000457	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KIT—muscle cancer	9.18e-06	0.000454	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—muscle cancer	8.95e-06	0.000442	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—FH—muscle cancer	8.94e-06	0.000442	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—muscle cancer	8.62e-06	0.000426	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ENO2—muscle cancer	8.52e-06	0.000421	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ENO2—muscle cancer	8.43e-06	0.000417	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—FH—muscle cancer	8.35e-06	0.000413	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—muscle cancer	8.19e-06	0.000405	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ENO2—muscle cancer	7.76e-06	0.000383	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	7.38e-06	0.000365	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	7.24e-06	0.000358	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MDM2—muscle cancer	7.23e-06	0.000357	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MED12—muscle cancer	7.12e-06	0.000352	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HMGA1—muscle cancer	7.05e-06	0.000349	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—muscle cancer	6.97e-06	0.000344	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—muscle cancer	6.96e-06	0.000344	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MED12—muscle cancer	6.85e-06	0.000339	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—muscle cancer	6.79e-06	0.000336	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—muscle cancer	6.79e-06	0.000336	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ENO2—muscle cancer	6.5e-06	0.000321	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FOXO4—muscle cancer	6.32e-06	0.000313	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ENO2—muscle cancer	6.24e-06	0.000309	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—muscle cancer	6.09e-06	0.000301	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—muscle cancer	5.84e-06	0.000289	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—muscle cancer	5.13e-06	0.000254	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—muscle cancer	5.06e-06	0.00025	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MED12—muscle cancer	5.05e-06	0.00025	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MED12—muscle cancer	4.72e-06	0.000233	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FOXO1—muscle cancer	4.67e-06	0.000231	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ENO2—muscle cancer	4.6e-06	0.000228	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—muscle cancer	4.3e-06	0.000213	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ENO2—muscle cancer	4.3e-06	0.000213	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KIT—muscle cancer	3.56e-06	0.000176	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—muscle cancer	3.36e-06	0.000166	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—muscle cancer	3.29e-06	0.000163	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—muscle cancer	2.97e-06	0.000147	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—muscle cancer	2.94e-06	0.000145	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MDM2—muscle cancer	2.8e-06	0.000139	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—muscle cancer	2.17e-06	0.000107	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—muscle cancer	1.6e-06	7.93e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—muscle cancer	1.5e-06	7.41e-05	CbGpPWpGaD
